Hydroxyzine Orifarm

Hydroxyzine hydrochloride, the active ingredient in Hydroxyzine Orifarm, is a first‑generation antihistamine presented as an oral tablet for oral use. It is employed to alleviate allergic skin conditions, relieve itching, reduce anxiety, provide sedation, and control nausea in adult patients.

GNH USA supplies Hydroxyzine Orifarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hydroxyzine Orifarm is a first‑generation antihistamine that acts on histamine H1 receptors to manage several conditions.

Allergic skin conditions: reduces inflammation and itching associated with urticaria and dermatitis. Pruritus: provides relief from generalized itching not responsive to other therapies. Anxiety: produces a calming effect useful in short‑term management of anxiety. Sedation: induces sleepiness for procedural sedation or insomnia. Nausea: helps control nausea and vomiting related to various causes.

Hydroxyzine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dry mouth: reduced salivation leading to a parched sensation. - Dizziness: light‑headedness or unsteady feeling. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm that may require medical attention. - Severe hypotension: marked drop in blood pressure causing faintness. - Stevens‑Johnson syndrome: rare skin reaction with blistering and detachment.

Before using Hydroxyzine Orifarm, consider the following safety measures.

Elderly patients: increased risk of sedation and falls. Driving or operating machinery: avoid until the effect on alertness is known. Concomitant CNS depressants: may enhance drowsiness and respiratory depression. Pregnancy: safety not established; use only if clearly needed. Renal or hepatic impairment: dose may require adjustment. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Hydroxyzine can interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - CNS depressants: additive sedation and respiratory depression. - Alcohol: enhances drowsiness and impairment. - QT‑prolonging agents: increased risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors: may raise hydroxyzine plasma levels. - Antihypertensives: potential additive blood‑pressure lowering effect.